Law360, New York (March 26, 2009) -- Five more end-payor plaintiffs, including Vista HealthPlan Inc., have voluntarily dismissed all claims against Pfizer Inc. in a consolidated class action that accused the pharmaceutical giant of a scheme to delay generic competition for the epilepsy drug Neurontin.
Vista HealthPlan, a painters union and three individual consumer plaintiffs lodged stipulations of voluntary dismissal on Tuesday in the U.S. District Court for the District of New Jersey, where litigation...
